Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

Roberts, Ivayla; Wright Muelas, Marina; M. Taylor, Joseph; Davison, Andrew; Xu, Yun; M. Grixti, Justine; Gotts, Nigel; Sorokin, Anatolii; Goodacre, Royston; B. Kell, Douglas

doi:10.1007/s11306-021-01859-3

Public

Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

Published in Metabolomics • Dec 20, 2021

Authors:

Ivayla Roberts

Marina Wright Muelas

Joseph M. Taylor

Abstract

INTRODUCTION: The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic acid sequences. Properties of the host response are not measured but are key in determining outcome. Although metabolic profiles are well suited to capture host state, most metabolomics studies ar...

View

Open Access

Subject

Coronavirus disease 2019 (COVID-19)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

2019-20 coronavirus outbreak

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!